摘要
目的探讨参芎注射液治疗冠心病心绞痛的有效性及安全性。方法计算机检索近年来Cochrane图书馆临床对照试验资料库、Pubmed、Embase、中国(CNKI)学术文献总库、万方数字化期刊库、中文科技期刊数据库相关文献资料,按纳入与排除标准选择随机对照试验、评价质量,提取资料,并用RevMan4.2软件对数据进行Meta分析。结果共初检出216篇文献,经筛选最终纳入11篇关于参芎注射液治疗冠心病心绞痛的随机对照研究。以心绞痛为疗效尺度:χ2=5.73,合并OR=3.71,95%CI[2.57,5.36],Z=7.00以心电图为疗效尺度:χ2=3.09,合并OR=3.39,95%CI[2.46,4.68],Z=7.43。结论参芎注射液治疗冠心病心绞痛安全有效。
Objective：To detect the effectiveness and safety of Shenxiong Injection on angina pectoris. Meth- ods：Trails on angina peetoris treated by Shenxiong Injection were retrieved fo Cochrane Library,Ovid-medline, Pubmed Embase, CNKI,Wanfang,VIP and CBM. These articles accordance with inclusion criteria were analyzed statistically by RevMan 4.2 soft. Resuits：A total of 11 random control trails in 216 subjects were included in this study. With the angina remission and the ECG improvement as the effect scales ,the respective Z values were 7.00 and 7.43. Conclusion：It is effective and safe for angina pectoris treated with Shenxiong Injection.
出处
《中国中医急症》
2012年第8期1272-1273,共2页
Journal of Emergency in Traditional Chinese Medicine
基金
吉林省科技厅科研项目(No.200905138)
